Work with us, win with us
QVQ HOLDING B.V. is pleased to announce that it has signed a binding letter of intent with ImmunoPrecise Antibodies Ltd., whereby ImmunoPrecise has agreed to acquire all of the issued and outstanding shares of QVQ.
New and further characterized products available
Rapid optical imaging of human breast tumour xenografts using anti Her2 VHH
Anti adhesive VHH targeting the integrin alpha 3 beta 1 (VLA-3)
Molecular Evolution of Broadly Neutralizing Llama Antibodies to the CD4-Binding Site of HIV-1
Age Related Diseases
Tissue Repair and Llama antibodies